Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-04

Clinical Trial Update: Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

View source ↗

Summary

The trial update reports that combining autologous stem cell transplant with zoledronic acid may improve outcomes in patients with previously untreated multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous Stem Cell Transplant
  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Multiple Myeloma | Status: COMPLETED